1245831-55-3 Usage
Chemical structure
The compound has a complex structure that includes a cyclobutane ring and a dioxaborolane group.
Dioxaborolane group
This group contains boron and oxygen atoms and is attached to a phenyl ring.
Nitrile functional group
The compound also contains a nitrile functional group, which consists of a carbon triple-bonded to a nitrogen.
Potential applications
Due to its unique structure, the compound likely has a wide range of potential applications, including use as a building block in organic synthesis or in the development of novel materials.
Hazardous properties
It is important to handle 1-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-cyclobutanecarbonitrile with care due to its potentially hazardous properties.
Reactivity
The compound may react with strong acids, strong bases, and strong oxidizing agents.
Solubility
The compound is likely soluble in organic solvents such as dichloromethane, tetrahydrofuran, and dimethyl sulfoxide.
Purity
The compound should be purified by column chromatography or other appropriate methods to remove any impurities.
Safety precautions
When handling 1-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-cyclobutanecarbonitrile, it is important to wear appropriate personal protective equipment (PPE), such as gloves, safety goggles, and a lab coat, and to work in a well-ventilated area or a fume hood.
Check Digit Verification of cas no
The CAS Registry Mumber 1245831-55-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,5,8,3 and 1 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1245831-55:
(9*1)+(8*2)+(7*4)+(6*5)+(5*8)+(4*3)+(3*1)+(2*5)+(1*5)=153
153 % 10 = 3
So 1245831-55-3 is a valid CAS Registry Number.
1245831-55-3Relevant academic research and scientific papers
COMPOUNDS AND THEIR METHODS OF USE
-
, (2018/06/12)
The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including Dravet syndrome or epilepsy are also provided herein.
INHIBITORS OF AKT ACTIVITY
-
Page/Page column 184, (2010/10/03)
The instant invention provides for substituted fused naphthyridine derivatives that inhibit Akt activity. In particular, the compounds disclosed selectively inhibit one or two of the Akt isoforms. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting Akt activity by administering the compound to a patient in need of treatment of cancer.
